HCPCS Code A9552 | Description & Billing Guidelines

HCPCS A9552 covers Fluorodeoxyglucose f–18 fdg, a radioactive form of glucose, and is administered to the patient with an injection.

What Is Fluorodeoxyglucose f–18 fdg?

Fluorodeoxyglucose f–18 fdg is a radioactive form of glucose. It can be produced by bombarding fluorine, F18. It has a half-life of approximately 110 minutes.

Fluorodeoxyglucose f–18 fdg, gets destroyed by positron emission.

What Is HCPCS Code A9552?

HCPCS code A9552 covers Fluorodeoxyglucose f–18 fdg, a radioactive form of glucose.

The provider uses Fluorodeoxyglucose f–18 fdg for diagnostic imaging, especially for positron emission tomography, or PET scans, a nuclear medicine imaging technique that produces a three-dimensional image of functional processes in the body.

Use A9552 for each dose of up to 45 millicuries or mCi of Fluorodeoxyglucose f–18 fdg.

Description

The official description of A9552 is defined by the HCPCS book as follows: “Fluorodeoxyglucose F-18 FDG, diagnostic, per study dose, up to 45 millicuries.”

Explanation

Bill HCPCS code A9552 when a patient received Fluorodeoxyglucose f–18 fdg through an injection.

The provider uses Fluorodeoxyglucose f–18 fdg to diagnose diseases such as coronary artery disease, CAD, disorders of the left ventricles, seizures due to epilepsy, and disorders of glucose metabolism.

The provider administers Fluorodeoxyglucose f–18 fdg, intravenously, or into a vein.

Billing Guidelines

Use HCPCS code A9552 for each study dose of up to 45 millicuries of Fluorodeoxyglucose f–18 fdg.

Resources

https://www.cms.gov/medicare-coverage-database/view/article.aspx?articleId=55052

https://files.nc.gov/ncdma/documents/files/Abbreviated%20PDP%20Catalog_8-31-18.pdf